NCT01378403|Completed
Loading search results
Sponsor study identifier
observational
22
1 country
1
Study Start
September 2007
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
July 2010
Actual (reported)Study Completion
July 2010
Actual (reported)Schizophrenia patients in comparing to normal controls show decreased ability to identify objects with decreased level of fragmentation, a task that is associated with magnocellular pathway function.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
July 2010
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 2007
Date type not reportedThis date has not been verified as actual or estimated.
July 2010
Actual (reported)July 2010
Actual (reported)June 20, 2011
Actual (reported)June 22, 2011
Actual (reported)Patients suffering from schizophrenia
Contact the study team to confirm eligibility.
Psychiatry Clinic - Sheba Medical Center
Ramat Gan, Israel
Revital Amiaz, MD
Sheba Medical Center
22 participants (actual enrollment reported by the registry).
First Submitted
June 20, 2011
First Posted
June 22, 2011
Study Start
September 2007
Date type not reportedThis date has not been verified as actual or estimated.
Add-on Simvastatin in Schizophrenia Trial
Primary Completion
July 2010
Actual (reported)Study Completion
July 2010
Actual (reported)Last Updated
June 22, 2011
Record last verified: 2011-06
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: